Two red phosphorus (RP)-based smokes (P60 and RPB), differing from each other mainly in RP content and in type of additive, were evaluated for in vitro cytotoxicity (cell viability by the trypan-blue exclusion method) and genotoxicity (comet assay) by exposing BEAS 2B human bronchial epithelial cells to the smokes in a laboratory-scale chamber for 5 min. The irritation potency of RPB smoke was studied in mice. A hexachloroethane-based smoke (HC/Zn/TNT) was used as a reference in the studies. A 5-min exposure of BEAS 2B cells to P60 smoke (1.1, 2.2 and 4.4 g/m(3), measured as H(3)PO(4)) did not induce any cytotoxic effects, while RPB smoke (1.3, 2.6 and 5.1g/m(3), measured as H(3)PO(4)) caused a mild decrease in cell viability at higher concentrations, without a clear dose-dependent effect. Neither of the RP smokes showed a genotoxic response in the comet assay with BEAS 2B cells, while HC/Zn/TNT was clearly genotoxic (0.9-3.5 g/m(3) as ZnCl(2)). In the mouse bioassay, head-only exposure to RPB smoke (20-450 mg/m(3) for 30 min as a single exposure, or 65-90 and 25-110 mg/m(3) - measured as H(3)PO(4) - for 30 min/day during 5 days) caused a concentration-dependent sensory irritation, which was evident as a decrease in respiratory rate and an increase in time-of-pause after inspiration, in a similar manner as with HC/Zn/TNT smoke. The concentration that caused a 50% decrease in respiratory frequency (RD(max)50) was calculated to be 1140 mg/m(3) for the RPB smoke and 145 mg/m(3) for the HC/Zn/TNT smoke. No pulmonary irritation was observed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mrgentox.2010.06.007DOI Listing

Publication Analysis

Top Keywords

rpb smoke
16
measured h3po4
12
irritation potency
8
cell viability
8
comet assay
8
smoke
8
beas cells
8
decrease respiratory
8
hc/zn/tnt smoke
8
rpb
5

Similar Publications

Article Synopsis
  • The SPIROMICS Study of Early COPD Progression (SOURCE) aims to investigate the biological reasons behind early-stage COPD in younger individuals who smoke, addressing a gap in current medical knowledge that hinders treatment development.
  • The study plans to enroll 649 participants aged 30-55 with a history of smoking, alongside 40 never-smoker controls, to collect comprehensive health data and analyze potential mechanisms of disease progression.
  • SOURCE seeks to use advanced imaging and biospecimen collection methods over three years to enhance understanding of COPD and contribute to better prevention and treatment strategies.
View Article and Find Full Text PDF

Objective: We report mortality outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) among people with type 2 diabetes diagnosed within 10 years and no recent history of cardiovascular events or cancer.

Research Design And Methods: Overall mortality rates and major causes of death were assessed over an average of 5 years of follow-up. Cause of death was adjudicated centrally by a committee masked to treatment assignment.

View Article and Find Full Text PDF

Accelerated progression of chronic obstructive pulmonary disease (COPD) is associated with increased risks of hospitalization and death. Prognostic insights into mechanisms and markers of progression could facilitate development of disease-modifying therapies. Although individual biomarkers exhibit some predictive value, performance is modest and their univariate nature limits network-level insights.

View Article and Find Full Text PDF

Flavored electronic cigarettes (ECs) present a serious health challenge globally. Currently, it is unknown whether the addition of highly popular menthol flavoring to e-liquid is associated with changes in the number of aerosolized particles generated or altered lung function. Here, we first performed preclinical studies using our novel robotic platform Human Vaping Mimetic Real-Time Particle Analyzer (HUMITIPAA).

View Article and Find Full Text PDF

Nicotine from cigarette smoke is a biologically active molecule that has pleiotropic effects in the airway, which could play a role in smoking-induced lung disease. However, whether nicotine and its metabolites reach sustained, physiologically relevant concentrations on airway surfaces of smokers is not well defined. To address these issues, concentrations of nicotine, cotinine, and hydroxycotinine were measured by mass spectrometry (MS) in supernatants of induced sputum obtained from participants in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS), an ongoing observational study that included never smokers, former smokers, and current smokers with and without chronic obstructive pulmonary disease (COPD).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!